Even though previous studies with genetic targeting of IKKβ in tumor mouse models did not address the effect of IKKβ deletion on tumor angiogenesis, it has been demostrated that IKKβ can promote tumor angiogenesis by phosphorylating TSC1 and activating mTOR in tumor cells [51]. The gene discussed is IKBKB; the disease is neoplasm.